These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 33252078)
1. Plasma Biomarkers of Alzheimer's Disease in African Americans. Deniz K; Ho CCG; Malphrus KG; Reddy JS; Nguyen T; Carnwath TP; Crook JE; Lucas JA; Graff-Radford NR; Carrasquillo MM; Ertekin-Taner N J Alzheimers Dis; 2021; 79(1):323-334. PubMed ID: 33252078 [TBL] [Abstract][Full Text] [Related]
2. Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease. Startin CM; Ashton NJ; Hamburg S; Hithersay R; Wiseman FK; Mok KY; Hardy J; Lleó A; Lovestone S; Parnetti L; Zetterberg H; Hye A; ; Strydom A Alzheimers Res Ther; 2019 Mar; 11(1):26. PubMed ID: 30902060 [TBL] [Abstract][Full Text] [Related]
3. The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease. Wang T; Xiao S; Liu Y; Lin Z; Su N; Li X; Li G; Zhang M; Fang Y Int J Geriatr Psychiatry; 2014 Jul; 29(7):713-9. PubMed ID: 24318929 [TBL] [Abstract][Full Text] [Related]
5. Plasma levels of Interleukin 18 but not amyloid-β or Tau are elevated in female depressive patients. Liu FR; Yang LY; Zheng HF; Zhou Y; Chen BB; Xu H; Zhang YW; Shen DY Compr Psychiatry; 2020 Feb; 97():152159. PubMed ID: 31931428 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease. Krishnan S; Rani P Biol Trace Elem Res; 2014 May; 158(2):158-65. PubMed ID: 24682919 [TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK-ADRC cohort. Foley KE; Winder Z; Sudduth TL; Martin BJ; Nelson PT; Jicha GA; Harp JP; Weekman EM; Wilcock DM Alzheimers Dement; 2024 Feb; 20(2):1374-1386. PubMed ID: 38011580 [TBL] [Abstract][Full Text] [Related]
8. Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer's disease patients and cognitively normal individuals. Boyer E; Deltenre L; Dourte M; Colmant L; Paître E; Sleegers K; Suelves N; Hanseeuw B; Kienlen-Campard P Alzheimers Res Ther; 2024 Jun; 16(1):141. PubMed ID: 38943196 [TBL] [Abstract][Full Text] [Related]
9. A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease. Shahpasand-Kroner H; Klafki HW; Bauer C; Schuchhardt J; Hüttenrauch M; Stazi M; Bouter C; Wirths O; Vogelgsang J; Wiltfang J Alzheimers Res Ther; 2018 Dec; 10(1):121. PubMed ID: 30526652 [TBL] [Abstract][Full Text] [Related]
10. Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis. Koychev I; Jansen K; Dette A; Shi L; Holling H J Alzheimers Dis; 2021; 79(1):177-195. PubMed ID: 33252080 [TBL] [Abstract][Full Text] [Related]
11. Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease. Wang MJ; Yi S; Han JY; Park SY; Jang JW; Chun IK; Kim SE; Lee BS; Kim GJ; Yu JS; Lim K; Kang SM; Park YH; Youn YC; An SSA; Kim S Alzheimers Res Ther; 2017 Dec; 9(1):98. PubMed ID: 29246249 [TBL] [Abstract][Full Text] [Related]
12. The Levels of Amyloid Xia C; Ma Q Comput Math Methods Med; 2021; 2021():7135399. PubMed ID: 34966443 [TBL] [Abstract][Full Text] [Related]
13. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease. Chatterjee P; Elmi M; Goozee K; Shah T; Sohrabi HR; Dias CB; Pedrini S; Shen K; Asih PR; Dave P; Taddei K; Vanderstichele H; Zetterberg H; Blennow K; Martins RN J Alzheimers Dis; 2019; 71(3):775-783. PubMed ID: 31424403 [TBL] [Abstract][Full Text] [Related]
14. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study. Pérez-Grijalba V; Romero J; Pesini P; Sarasa L; Monleón I; San-José I; Arbizu J; Martínez-Lage P; Munuera J; Ruiz A; Tárraga L; Boada M; Sarasa M J Prev Alzheimers Dis; 2019; 6(1):34-41. PubMed ID: 30569084 [TBL] [Abstract][Full Text] [Related]
15. Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease. Chong JR; Ashton NJ; Karikari TK; Tanaka T; Saridin FN; Reilhac A; Robins EG; Nai YH; Vrooman H; Hilal S; Zetterberg H; Blennow K; Lai MKP; Chen CP Alzheimers Dement; 2021 Oct; 17(10):1649-1662. PubMed ID: 33792168 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study. Han MR; Schellenberg GD; Wang LS; BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310 [TBL] [Abstract][Full Text] [Related]
17. Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease. Tzen KY; Yang SY; Chen TF; Cheng TW; Horng HE; Wen HP; Huang YY; Shiue CY; Chiu MJ ACS Chem Neurosci; 2014 Sep; 5(9):830-6. PubMed ID: 25054847 [TBL] [Abstract][Full Text] [Related]
18. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study. de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776 [TBL] [Abstract][Full Text] [Related]